In contrast, we could not demonstrate any prognostic significance of stromal PD‐L1 immunoreactivity in CRC without NCRT, despite the positive correlation between stromal PD‐L1+ and CD8+ expression. The gene discussed is CD274; the disease is colorectal carcinoma.